BK0689 Cosmetics Concept
- 2122.033
- -5.777-0.27%
Pien Tsai (600436): Steady price increases for core main products and explores the construction of multiple categories
Huaxi Biotech (688363) 2023 and 2024 first quarter results review: Q1 performance picked up, raw materials and pharmaceutical business growth exceeded expectations
Shuiyang Co., Ltd. (300740) Incident Review: Imperial Clay Fair held the 18th anniversary press conference to launch a new brand system and research results, and brand adjustments are progressing steadily
Huaxi Biotech (688363): Skincare adjustments in 23 years dragged down performance, 24Q1 performance surged, and an inflection point appeared
Bettany (300957): Short-term pressure on 23-year performance, steady month-on-month recovery in 24Q1
Huaxi Biotech (688363): Strong raw materials+medical terminal business, looking forward to the skincare business returning to a growth trajectory
Bettany (300957): 24Q1 deduction +22%, showing that organizational adjustments at an inflection point may gradually come to fruition
Coase Co., Ltd. (300856): Non-net profit deducted in 24Q1 of 204 million yuan, a year-on-year increase of 29.78%. New emollient and moisturizer processes opened
Shuyang Co., Ltd. (300740): “own+agent” two-wheel drive private brand moving towards multi-brand development
Lihe Kechuang (002243): Short-term performance is under pressure and looks forward to subsequent restoration
Huaxi Biotech (688363) Review Report: 23 business adjustments, 24Q1 performance repair and recovery
Pien Tsai (600436): Steady growth in 2023, excellent sales under 2024Q1 liver disease drug price increase
Bettany (300957): Weak performance in '23, marginal improvement in Q1 in '24
Pien Tsai (600436): Rapid growth of large single products, rising costs affect gross profit
Bettany (300957): Performance is under pressure, main brand moves towards 2.0 era & organizational optimization drives management improvement
Freda (600223): Cosmetics Q1 growth rate is steady, real estate returns are abundant and cash is expected to help growth
Huaxi Biotech (688363): 24Q1 performance gradually recovered, looking forward to the results of skincare business adjustments
Huaxi Biotech (688363): The inflection point of Q1 is beginning to show, and we expect skincare products to return to growth after adjustment
La Fontaine (603630): Stable performance growth in 23 years, looking forward to cultivating new growth poles
Bethany (300957): Main brand growth is gradually stabilizing, and this year is expected to consolidate the quality of operations